LABD logo

Direxion Daily S&P Biotech Bear 3X Shares (LABD)

$21.05

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on LABD

AUM

$80126404

P/E ratio

--

Dividend yield

10.3936%

Expense ratio

1.07%

Beta

-2.597837

Price on LABD

Previous close

$21.12

Today's open

$21.06

Day's range

$20.83 - $21.70

52 week range

$19.69 - $160.50

Profile about LABD

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

LABD industries and sectors

Alternatives

Trading Tools

Top holdings in LABD
News on LABD

Top Performing Leveraged/Inverse ETFs: 05/11/2025

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • May 14, 2025

news preview

5 Leveraged/Inverse ETFs That Gained More Than 25% in April

Market volatility boosts demand for leveraged and inverse-leveraged ETFs. A few of them gained more than 25% last month.

news source

Zacks Investment Research • May 1, 2025

news preview

Top Performing Leveraged/Inverse ETFs: 04/06/2025

Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • Apr 10, 2025

news preview

Leveraged ETF Winners Amid Wall Street's Worst Week Since 2020

Inverse and volatility ETFs won in the worst week of Wall Street since 2020.

news source

Zacks Investment Research • Apr 7, 2025

news preview

Top Performing Leveraged/Inverse ETFs: 11/17/2024

Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • Nov 19, 2024

news preview

Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

news source

ETF Trends • Aug 1, 2024

news preview

Can Biotech Heal Itself?

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

news source

ETF Trends • Jul 30, 2024

news preview

5 Inverse ETFs That Gained More Than 20% in April

The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.

news source

Zacks Investment Research • May 1, 2024

news preview

Top Performing Leveraged/Inverse ETFs: 04/21/2024

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

news source

ETF Trends • Apr 23, 2024

news preview

5 Best Inverse-Leveraged ETFs of Last Week

Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.

news source

Zacks Investment Research • Apr 23, 2024

news preview

¹ Disclosures

Get started with M1

Invest in Direxion Daily S&P Biotech Bear 3X Shares

Open an M1 investment account to buy and sell Direxion Daily S&P Biotech Bear 3X Shares commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in LABD on M1